PlainRecalls
FDA Devices Moderate Class II Ongoing

DBX Demineralized Bone Matrix Putty 10cc-Indicated for treatment of surgically created osseous defects or osseous defects created from traumatic injury. Model Number: 038100

Reported: November 29, 2023 Initiated: September 22, 2023 #Z-0323-2024

Product Description

DBX Demineralized Bone Matrix Putty 10cc-Indicated for treatment of surgically created osseous defects or osseous defects created from traumatic injury. Model Number: 038100

Reason for Recall

Units are labeled as 10cc; however the units have a fill volume of 1cc units. This may result in prolongation of surgery.

Details

Units Affected
18 units
Distribution
US Nationwide distribution in the states of PA, TX, WA.
Location
Edison, NJ

Frequently Asked Questions

What product was recalled?
DBX Demineralized Bone Matrix Putty 10cc-Indicated for treatment of surgically created osseous defects or osseous defects created from traumatic injury. Model Number: 038100. Recalled by Musculoskeletal Transplant Foundation, Inc.. Units affected: 18 units.
Why was this product recalled?
Units are labeled as 10cc; however the units have a fill volume of 1cc units. This may result in prolongation of surgery.
Which agency issued this recall?
This recall was issued by the FDA Devices on November 29, 2023. Severity: Moderate. Recall number: Z-0323-2024.